STOCK TITAN

Monopar Therapeutics (MNPR) CEO nets shares after RSU vesting and tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Monopar Therapeutics Chief Executive Officer Chandler Robinson reported compensation-related stock activity. On June 30, 2026, 12,873 restricted stock units vested and settled into the same number of common shares. The issuer withheld 4,084 shares at $92.59 per share to cover applicable tax obligations.

Following these transactions, Robinson holds 99,267 shares of Monopar common stock directly and 62,815 shares indirectly through the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020. The filing reflects routine RSU vesting and associated tax-withholding dispositions, not open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider Robinson Chandler
Role Chief Executive Officer
Type Security Shares Price Value
Exercise Restricted Stock Unit 12,873 $0.00 --
Exercise Common Stock 12,873 $0.00 --
Tax Withholding Common Stock 4,084 $92.59 $378K
holding Common Stock -- -- --
Holdings After Transaction: Restricted Stock Unit — 93,403 shares (Direct, null); Common Stock — 103,351 shares (Direct, null); Common Stock — 62,815 shares (Indirect, See Footnote)
Footnotes (1)
  1. Represents shares acquired on vesting and settlement of restricted stock units. Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units. Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020. On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. On December 2, 2025, the reporting person was granted 49,133 restricted stock units, vesting 6/48ths (6,142) on June 30, 2026, and 3/48ths (3,071 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
RSU shares vesting 12,873 shares Restricted stock units vested and settled into common stock on June 30, 2026
Shares withheld for taxes 4,084 shares at $92.59/share Withheld by issuer to pay applicable withholding tax upon RSU vesting
Direct holdings after transaction 99,267 shares Common stock directly owned by Chandler Robinson after June 30, 2026 transactions
Indirect trust holdings 62,815 shares Common stock held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020
Derivative exercise shares 12,873 shares Exercise/conversion of restricted stock units into common stock (M-code transaction)
Restricted stock units financial
"On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths..."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Irrevocable Trust financial
"Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.
vesting financial
"Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Robinson Chandler

(Last)(First)(Middle)
1000 SKOKIE BLVD SUITE 350

(Street)
WILMETTE ILLINOIS 60091

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Monopar Therapeutics [ MNPR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/30/2026M12,873A(1)103,351D
Common Stock06/30/2026F4,084(2)D$92.5999,267D
Common Stock62,815ISee Footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Unit(1)06/30/2026M12,873 (4)(5)(6) (4)(5)(6)Common Stock12,873$093,403D
Explanation of Responses:
1. Represents shares acquired on vesting and settlement of restricted stock units.
2. Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
3. Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
4. On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
5. On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
6. On December 2, 2025, the reporting person was granted 49,133 restricted stock units, vesting 6/48ths (6,142) on June 30, 2026, and 3/48ths (3,071 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Quan Vu, Attorney-in-fact07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Monopar Therapeutics (MNPR) report for its CEO?

Monopar Therapeutics CEO Chandler Robinson reported RSU vesting and related tax withholding. On June 30, 2026, 12,873 restricted stock units vested into common shares, and 4,084 of those shares were withheld by the issuer to satisfy tax obligations rather than sold on the open market.

How many Monopar (MNPR) shares did the CEO receive from RSU vesting?

Chandler Robinson received 12,873 Monopar common shares from RSU vesting. These shares resulted from the settlement of restricted stock units on June 30, 2026, as part of previously granted equity awards that vest over time according to schedules described in the filing footnotes.

How many Monopar (MNPR) shares were withheld for the CEO’s taxes?

Monopar withheld 4,084 shares to cover the CEO’s tax liability. The shares were withheld at $92.59 per share in connection with the June 30, 2026 vesting event. This F-code transaction is a tax-withholding disposition, not an open-market sale by the executive.

What are the Monopar (MNPR) CEO’s share holdings after this Form 4?

After the reported transactions, Chandler Robinson holds 99,267 shares directly. He also has indirect ownership of 62,815 shares through the Chandler D. Robinson Irrevocable Trust. These figures reflect his reported stake immediately following the June 30, 2026 RSU vesting and tax-withholding events.

What do the Monopar (MNPR) RSU grants in the footnotes indicate?

The footnotes describe multiple RSU grants with structured vesting schedules. Grants from February 1, 2023, March 4, 2025, and December 2, 2025 each vest in tranches through December 31, 2026, 2028, and 2029, respectively, delivering one common share for each vested restricted stock unit.

Is the Monopar (MNPR) CEO’s Form 4 a buy or sell signal?

The Form 4 reflects RSU vesting and tax withholding, not open-market trading. Shares were acquired through derivative exercises of restricted stock units, while 4,084 shares were withheld by the issuer for taxes, a routine mechanism that does not represent a discretionary market sale by the CEO.